A tau PET study with 18F-THK5351 on neurodegenerative disorders patients.
Not Applicable
Recruiting
- Conditions
- Patients who are suspected neurodegenerative disorders including Alzheimer disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, frontotemporal lobe degeneration, Parkinson's disease, dementia with Lewy bodies, and others including possibly tau positive, negative, and inconstant disorders.
- Registration Number
- JPRN-UMIN000036956
- Lead Sponsor
- agoya City Rehabilitation Agency
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients having history of seizure, alcoholism, or any kind of drug dependency. Patients recognized to be inappropriate by anyone of attending physicians or study staffs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the distribution of tau deposit among disorders manifesting parkinsonism or dementia.
- Secondary Outcome Measures
Name Time Method Relationship between clinical pictures and distributions of tau and amyloid deposit.